REDUCED FOREARM BONE MINERAL CONTENT AND BIOCHEMICAL EVIDENCE OF INCREASED BONE TURNOVER IN WOMEN WITH EUTHYROID GOITRE TREATED WITH THYROID HORMONE
- 1 July 1990
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 33 (1), 107-117
- https://doi.org/10.1111/j.1365-2265.1990.tb00471.x
Abstract
We used single-photon absorptiometry to assess forearm bone mineral content (BMC/BW) (arbitrary units normalized for bone width) at a proximal site (PBMC/BW) and at a more distal site (DBMC/BW) in 60 women treated with 25-50 micrograms T3 or 50-100 micrograms T4 for euthyroid goitre, in 13 untreated goitre patients, and in 2 controls matched for age and menopausal state for each goitre patient. BMC/BW was not significantly different between untreated goitre patients and controls. In 36 premenopausal patients, treated for 5.8 +/- 5.4 years (mean +/- SD) a slight decrease in PBMC/BW of about 5% compared to controls to controls was observed (PBMC/BW 1.42 +/- 0.19 vs 1.49 +/- 0.13, P less than 0.05). In 24 postmenopausal patients, treated for 10.0 +/- 5.8 year, a 20% deficit in BMC/BW compared to controls was found (DBMC/BW 0.80 +/- 0.18 vs 1.06 +/- 0.20, P less than 0.001 and PBMC/BW 1.14 +/- 0.20 vs 1.42 +/- 0.19, P less than 0.001). Biochemical indices of bone metabolism in 43 pre and post-menopausal patients and 43 controls showed in the patients a higher serum alkaline phosphatase activity (AP) (P less than 0.01 and P less than 0.05 and serum osteocalcin (NS and P less than 0.05). AP was negatively correlated with TSH levels and, in postmenopausal patients, with DBMC/BW and PBMC/BW. Our results suggest that treatment of euthyroid women with moderate doses of thyroid hormone increases bone turnover with clear adverse effects on bone mineral status in postmenopausal patients.Keywords
This publication has 15 references indexed in Scilit:
- Exogenous triiodothyronine activates bone remodelingBone, 1987
- Axial and Appendicular Bone Mineral Density in Patients with Long-Term Deficiency or Excess of CalcitoninThe New England Journal of Medicine, 1987
- Suppressive Therapy with Levothyroxine for Solitary Thyroid NodulesThe New England Journal of Medicine, 1987
- Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?BMJ, 1987
- Trabecular bone remodeling and bone balance in hyperthyroidismBone, 1985
- Effect of hyperthyroidism and its treatment on bone mineral contentArchives of Internal Medicine, 1985
- RECURRENCE OF NONTOXIC GOITRE WITH AND WITHOUT POSTOPERATIVE THYROXINE MEDICATIONClinical Endocrinology, 1984
- SPINAL BONE MINERAL CONTENT IN MYXOEDEMA AND THYROTOXICOSIS. EFFECTS OF THYROID HORMONE(S) AND ANTITHYROID TREATMENTClinical Endocrinology, 1983
- Exogenous hyperthyroidism with osteoporosisArchives of Internal Medicine, 1983
- OSTEOPOROSIS AND FRACTURES FOLLOWING THYROTOXICOSISThe Lancet, 1971